STUDY OBJECTIVES: To examine the efficacy of imagery rehearsal (IR) combined with cognitive behavioral therapy for insomnia (CBT-I) compared to CBT-I alone for treating recurrent nightmares in military veterans with posttraumatic stress disorder (PTSD). METHODS: In this randomized controlled study, 108 male and female United States veterans of the Iraq and Afghanistan conflicts with current, severe PTSD and recurrent, deployment-related nightmares were randomized to six sessions of IR + CBT-I (n = 55) or CBT-I (n = 53). Primary outcomes were measured with the Nightmare Frequency Questionnaire (NFQ) and Nightmare Distress Questionnaire (NDQ). RESULTS: Improvement with treatment was significant (29% with reduction in nightmare frequency and 22% with remission). Overall, IR + CBT-I was not superior to CBT-I (NFQ: -0.12; 95% confidence interval = -0.87 to 0.63; likelihood ratio chi square = 4.7(3), P = .2); NDQ: 1.5, 95% confidence interval = -1.4 to 4.4; likelihood ratio chi square = 7.3, P = .06). CONCLUSIONS: Combining IR with CBT-I conferred no advantage overall. Further research is essential to examine the possibly greater benefit of adding IR to CBT-I for some subgroups of veterans with PTSD. CLINICAL TRIAL REGISTRATION: Registry: ClinicalTrials.gov; Title: Cognitive Behavioral Therapy (CBT) for Nightmares in Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) Veterans; Identifier: NCT00691626; URL: https://clinicaltrials.gov/ct2/show/NCT00691626.
RCT Entities:
STUDY OBJECTIVES: To examine the efficacy of imagery rehearsal (IR) combined with cognitive behavioral therapy for insomnia (CBT-I) compared to CBT-I alone for treating recurrent nightmares in military veterans with posttraumatic stress disorder (PTSD). METHODS: In this randomized controlled study, 108 male and female United States veterans of the Iraq and Afghanistan conflicts with current, severe PTSD and recurrent, deployment-related nightmares were randomized to six sessions of IR + CBT-I (n = 55) or CBT-I (n = 53). Primary outcomes were measured with the Nightmare Frequency Questionnaire (NFQ) and Nightmare Distress Questionnaire (NDQ). RESULTS: Improvement with treatment was significant (29% with reduction in nightmare frequency and 22% with remission). Overall, IR + CBT-I was not superior to CBT-I (NFQ: -0.12; 95% confidence interval = -0.87 to 0.63; likelihood ratio chi square = 4.7(3), P = .2); NDQ: 1.5, 95% confidence interval = -1.4 to 4.4; likelihood ratio chi square = 7.3, P = .06). CONCLUSIONS: Combining IR with CBT-I conferred no advantage overall. Further research is essential to examine the possibly greater benefit of adding IR to CBT-I for some subgroups of veterans with PTSD. CLINICAL TRIAL REGISTRATION: Registry: ClinicalTrials.gov; Title: Cognitive Behavioral Therapy (CBT) for Nightmares in Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) Veterans; Identifier: NCT00691626; URL: https://clinicaltrials.gov/ct2/show/NCT00691626.
Authors: B Krakow; M Hollifield; R Schrader; M Koss; D Tandberg; J Lauriello; L McBride; T D Warner; D Cheng; T Edmond; R Kellner Journal: J Trauma Stress Date: 2000-10
Authors: B Krakow; M Hollifield; L Johnston; M Koss; R Schrader; T D Warner; D Tandberg; J Lauriello; L McBride; L Cutchen; D Cheng; S Emmons; A Germain; D Melendrez; D Sandoval; H Prince Journal: JAMA Date: 2001-08-01 Impact factor: 56.272
Authors: Paula P Schnurr; Matthew J Friedman; David W Foy; M Tracie Shea; Frank Y Hsieh; Philip W Lavori; Shirley M Glynn; Melissa Wattenberg; Nancy C Bernardy Journal: Arch Gen Psychiatry Date: 2003-05
Authors: Barry J Krakow; Dominic C Melendrez; Lisa G Johnston; James O Clark; Erin M Santana; Teddy D Warner; Michael A Hollifield; Ron Schrader; Brandy N Sisley; Samuel A Lee Journal: J Clin Psychiatry Date: 2002-08 Impact factor: 4.384
Authors: Kristi E Pruiksma; Danica C Slavish; Daniel J Taylor; Jessica R Dietch; Hannah Tyler; Megan Dolan; AnnaBelle O Bryan; Craig J Bryan Journal: Int J Behav Med Date: 2021-04
Authors: Rachel M Ranney; Rebecca Gloria; Thomas J Metzler; Joy Huggins; Thomas C Neylan; Shira Maguen Journal: J Clin Sleep Med Date: 2022-07-01 Impact factor: 4.324
Authors: Kristi E Pruiksma; Daniel J Taylor; Jim Mintz; Karin L Nicholson; Matthew Rodgers; Stacey Young-McCaughan; Brittany N Hall-Clark; Brooke A Fina; Katherine A Dondanville; Briana Cobos; Sophie Wardle-Pinkston; Brett T Litz; John D Roache; Alan L Peterson Journal: J Clin Sleep Med Date: 2019-11-26 Impact factor: 4.062